|
|
Volumn 2, Issue 1, 2009, Pages 1-2
|
|
Letter from the editor
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA CHEMOKINE;
CELECOXIB;
DEGUELIN;
EFLORNITHINE;
HEAT SHOCK PROTEIN 90 INHIBITOR;
MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;
SULINDAC;
ADENOMA;
BREAST CANCER;
CANCER PREVENTION;
CANCER RESEARCH;
CANCER RISK;
CLINICAL TRIAL;
COLORECTAL ADENOMA;
EDITORIAL;
ENERGY BALANCE;
HEAD AND NECK CANCER;
HUMAN;
MEDLINE;
NEOPLASM;
NONHUMAN;
PRIORITY JOURNAL;
PUBLICATION;
RISK ASSESSMENT;
MEDICAL RESEARCH;
BIOMEDICAL RESEARCH;
HUMANS;
NEOPLASMS;
PERIODICALS AS TOPIC;
PUBMED;
|
|
EID: 68349087962
PISSN: 19406207
EISSN: None
Source Type: Journal
DOI: 10.1158/1940-6207.CAPR-08-0221 Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|